BOTOX by the numbers
3,181,592: Number of BOTOX® Cosmetic treatments administered in the United States in 2006 alonei
• 1,000,000s: People who received treatment with BOTOX® for medical and aesthetic purposes around the worldii
• 300,000: Number of men who received treatment with BOTOX® Cosmetic in 2006iii
• 10,000: People in clinical trialsiv
• 3,000: Publications on Botulinum Toxin Type A in scientific and medical journalsv
• 100: Years of study into botulinum neurotoxinsvi
• 97: Percentage of people satisfied with their BOTOX® Cosmetic treatment based on a survey of approximately 1,000 patientsvii
• 75: Countries around the world who have approved use of BOTOX®
• 20: BOTOX® indications approved by regulatory authorities around the world, including the aesthetic indication
• 18: Years since U.S. Food and Drug Administration (FDA) approved BOTOX® to treat excessive eye blinking and crossed eyes
• 11: Descriptor for the glabellar (vertical) lines between the brows which can be treated with BOTOX® Cosmetic, that can help improve one’s overall facial appearance
• 8: Years since FDA approval of BOTOX® for the treatment of cervical dystonia (painful neck twisting condition) in adults
• 6: Years since FDA approval of BOTOX® Cosmetic for the treatment of the moderate to severe glabellar (vertical) lines between the brows in adults 18 to 65
• 4: Years since FDA approval of BOTOX® for the treatment of severe primary hyperhidrosis (excessive underarm sweating) inadequately managed with topical agents
• 1: Rank of BOTOX® Cosmetic on list of “Top 5 Surgical & Nonsurgical Physician Administered Cosmetic Procedures,”viii according to American Society for Aesthetic Plastic Surgery
Information supplied by Allergan.
© 2008 Allergan, Inc. Irvine, CA 92612. ® marks owned by Allergan, Inc.
___________________________________________________
i. American Society for Aesthetic Plastic Surgery Quick Facts http://www.surgery.org/download/2006stats.pdf
ii. Allergan press release “Allergan, Inc Responds to Public Citizen’s Allegation Regarding a Fatality Following BOTOX® Cosmetic
Treatment” 01/25/08
iii. American Society for Aesthetic Plastic Surgery Quick Facts http://www.surgery.org/download/2006stats.pdf
iv. Allergan press release “Allergan, Inc Comments on BOTOX® (Botulinum Toxin Type A) Safety Profile” Released 01/24/08
v. BOTOX® History and Development Fact Sheet, updated 01.04.08
vi. BOTOX® History and Development Fact Sheet, updated 01.04.08
vii. Aesthetic Surgery Education & Research Foundation press release “First-of-its-kind Survey Finds That BOTOX Cosmetic has
Gone Mainstream” Released 04/28/06
viii. American Society for Aesthetic Plastic Surgery Top 5 Surgical & Nonsurgical Cosmetic Procedures
http://www.surgery.org/download/2006-Top5.pdf

Comments